Gait and Energy Expenditure in Children With Lower Limb Amputation (MAPEDE)
NCT ID: NCT07076602
Last Updated: 2025-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
48 participants
OBSERVATIONAL
2025-09-01
2028-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic Evaluation of Ankle Joint and Muscle Mechanics in Children With Spastic Equinus Deformity Due to Cerebral Palsy
NCT02814786
The Effect of Lower Limb Deformities (LLD) on Children's Gait and on Energy Expenditure
NCT01255241
Comparison of Two Ankle Foot Orthosis on Mobility, Participation and Adhesion in Childrend With Cerebral Palsy
NCT07301593
Independent Walking Onset of Children With Cerebral Palsy
NCT03902886
The Effect of AFOs on the EMG of Children With CP
NCT06532981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One session will include a physiotherapy assessment and the evaluation of energy expenditure (oxygen consumption and Physiological Cost Index PCI) during a of 6-minute walking test.
The other session will include the assessment of kinematic parameters during a gait analysis and again the assessment of energy expenditure during a of 6-minute walking test.
FOLLOW-UP VISIT The report of all tests carried out will be made available to the child's physician and physiotherapists. An electronic questionnaire will be sent to them three to six months following the child' inclusion, to assess the usefulness of the information provided by the energy expenditure measurement and gait analysis in their practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gait and energy expenditure
Inclusion of a single day comprising two sessions of 2.5 hours each (both sessions can be interchanged) SESSION 1 : Physiotherapy assessment + Measurement of energy expenditure SESSION 2 : Measurement of kinematic parameters by gait analysis + Measurement of energy expenditure
Gait and energy expenditure
SESSION 1:
Physiotherapy assessment: clinical parameters, length of limb segments, range of motion of the lower limbs, muscle strength of each lower limb joint and trunk.
Measurement of energy expenditure:
6-minute walking test with prosthesis, at a constant submaximal speed, with portable gas exchange analyzer to measure oxygen consumption and a connected device to calculate the Physiological Cost Index.
* During test: recording of heart rate at the start, each minute, at the end then 5 minutes after the end, recording of the effort perceived by the child each minute (Borg scale)
* At the end : questionnaire to assess child level of acceptability regarding the measurement of the O2 (Oxygen) consumption
SESSION 2:
Measurement of kinematic parameters by gait analysis: the child will be requested to walk with their prosthesis and shoes at spontaneous speed and at maximal gait speed.
The second measurement of energy expenditure will be conducted using the same procedure as the first.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait and energy expenditure
SESSION 1:
Physiotherapy assessment: clinical parameters, length of limb segments, range of motion of the lower limbs, muscle strength of each lower limb joint and trunk.
Measurement of energy expenditure:
6-minute walking test with prosthesis, at a constant submaximal speed, with portable gas exchange analyzer to measure oxygen consumption and a connected device to calculate the Physiological Cost Index.
* During test: recording of heart rate at the start, each minute, at the end then 5 minutes after the end, recording of the effort perceived by the child each minute (Borg scale)
* At the end : questionnaire to assess child level of acceptability regarding the measurement of the O2 (Oxygen) consumption
SESSION 2:
Measurement of kinematic parameters by gait analysis: the child will be requested to walk with their prosthesis and shoes at spontaneous speed and at maximal gait speed.
The second measurement of energy expenditure will be conducted using the same procedure as the first.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Congenital (transverse agenesis with break in limb continuity) or acquired (any etiology) transfemoral or transtibial amputation. \[In the case of femoral agenesis, the flexion axis of the prosthetic knee must coincide with the contralateral one to optimize the analysis of the kinematic parameters of gait\].
* Definitive prosthesis in place (no restriction on choice of prosthetic components)
* Legal representatives not opposing participation in the study for the child
Exclusion Criteria
* Progressive pathology associated with amputation (unstabilized sarcoma for example) which can strongly influence walking and/or energy expenditure
* Patient already included in an interventional research protocol that could lead to bias in the present study
7 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LAURANE MAIGNAN-GOTER
Role: PRINCIPAL_INVESTIGATOR
Centre 01 - CHU de RENNES, Hôpital Pontchaillou
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre 02 - CHU Brest, Hôpital Morvan
Brest, , France
Centre 04 - Hospices Civils de Lyon, Hôpital Mère Enfant Groupement Hospitalier Est
Bron, , France
Centre 03 - CHU Dijon, Hôpital Le Bocage
Dijon, , France
Centre 01 - CHU de RENNES, Hôpital Pontchaillou
Rennes, , France
Hôpitaux Paris Est Val-de-Marne, Hôpital Saint-Maurice
Saint-Maurice, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A01990-47
Identifier Type: REGISTRY
Identifier Source: secondary_id
35RC23_9872_MAPEDE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.